Repligen Elects Earl Henry, M.D. to the Board of... ( WALTHAM Mass. Dec. 13 /- Repligen...)

Repligen Elects Earl Henry, M.D. to the Board of Directors

Date:12/13/2007

WALTHAM, Mass., Dec. 13 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that Dr. Earl Webb Henry, M.D. has been elected to its Board of Directors. Dr. Henry is a highly experienced executive with worldwide clinical and regulatory expertise in the development of therapeutics for disorders affecting the Central Nervous System.

"We are very pleased to welcome an executive with Earl's industry knowledge and drug development expertise to our Board," stated Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "Earl's strategic guidance and relationships within the medical community will be an invaluable asset to the Company as we develop and expand our emerging CNS pipeline."

Dr. Henry has held numerous executive level positions including Senior Vice President and Head, Worldwide Clinical Research and Regulatory Affairs for Cephalon, Inc., Vice President, Clinical Research for Guilford Pharmaceuticals Inc., Global Head of Central Nervous System Therapeutic Area for Sandoz Research Institute and Senior Associate Director of Clinical Research for Pfizer. Dr. Henry has participated in the development and approval of numerous neurologic and psychiatric drugs. Dr. Henry earned his medical degree from the University of Chicago and completed his residence and fellowship at Harvard Medical School in neurology and neuropathology. Dr. Henry is currently Senior Vice President, Medical Affairs for inVentiv Clinical Solutions, a premier provider of clinical outsourcing solutions.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, w
'/>"/>

SOURCE Repligen Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
2. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
3. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
4. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
5. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
6. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
7. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
8. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
9. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
10. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
11. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency

Post Your Comments:

(Date:11/25/2009)...ire/-SentinelleMedicalInc.,aleadingmanufacturerofb...hesasuiteofnewleadingedgeclinicalapplicationsonits...sRadiologicalSocietyofNorthAmerica(RSNA)annualmeet...eapplicationsleveragetheuniquehighqualityimagesgen...upportmultipleimagingmodalitiesformulti-parametric...

(Date:11/25/2009)...ments,Business,andPressJoinEfforttoEducate ,, ...gain,theNationalBipolarFoundationandtheMedicAlertF...ilStable"program,whichisnowbeingwidelyacceptedasap...,theNationalBipolarFoundationreceivedaproclamation...t.GovernorofLouisianaMitchLandrieu.TheNationalBipo...

(Date:11/25/2009)... too short to draw definite conclusions, experts s...ews) -- In diabetic patients with blocked coronary...tcomes at one year whether patients undergo bypass...earchers report. , Bypass surgery has been the ...nary artery disease. However, less invasive approa...

(Date:11/25/2009)...s few signs of trouble with the H1N1 vaccine, , ...The ongoing H1N1 swine flu pandemic may be driving...ger patients, a U.S. health official said Wednesda...mococcal infections around the country," Dr. Anne ...nization and Respiratory Diseases at the U.S. Cent...

(Date:11/25/2009)...tal cancer also can reverse a rare stomach disorde...the disease, researchers at Vanderbilt University ...ase causes thickening of the stomach lining, sever...anemia and swelling in the feet and ankles due to ...astric cancer. Previously, the only effective trea...

Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4 Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2

[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [0] First Time-Door is Open for Family Discussion of Bipolar Disorder [1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Swine Flu Tied to Rise in Pneumonias Among Young [1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder

... research that delivers,timely studies with operat...nsulting and early-stage commercialization is now ... research repository managed by research and,consu... links to each of the two new,studies at this addr...

...ges, effort to reduce costs , , ST. LOUIS, Feb. 9...unced today it is in the process of reducing its w... part of an overall cost-cutting program as the co...y suspension of product manufacturing and shipment...

...ith the holiday from fruit and wine to massage can..., Mich., Feb. 9 The sweet delights of Valentine,s...colate, wine and romance can be good for your hear...s, grapes and wine that can lower blood pressure a...

...g Clinicians Exchange (PCE) has formed a partnersh...tion (CDC) to provide immunization continuing educ...ysician assistants (PAs) throughout the United Sta...ut the year as part of the PCE national symposia s...

...ia panel to reveal secrets behind healthy changes ...lling author and RealAge cofounder Michael Roizen,...behavior and patient success when he addresses the...rmed her life, Dr. Roizen will relay insights he,s...

...ire-Asia/ -- Chindex International, Inc.,(Nasdaq: ...of Western healthcare,products and services in the...cial results for the third quarter of fiscal year ...8. Revenue,from the healthcare services division i...

Best Practice Database adds Research Highlighting the Value of Internal Consulting and Early-Stage Commercialization Groups in the Pharmaceutical Industry KV Pharmaceutical Company Reduces Workforce Valentine's Day Indulgences Can Be Heart Healthy Practicing Clinicians Exchange Forms Partnership with CDC Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results

(Date:11/25/2009)...f.,Nov.25/PRNewswire/--PraxisElectronicMedicalReco...fFamilyPhysicians,(AAFP)FamilyPracticeManagement(F...lquality,healthmaintenance,anddiseasemanagement,al...anked#1amongdoctorsindicatingtheirEMRhadapositivee...nkednumberoneinthecountryinprovidingexcellenttrain...

(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasd...ittedtodiscovering,developingandcommercializingnov...ultsforthefiscalyearendedSeptember30,2009.AtSeptem...ivalentsandshortterminvestments. ,, PipelineUp...e2bTrial ,, InlateNovember2009,anindependentD...

(Date:11/25/2009)....,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappr...leosidereversetranscriptaseinhibitor(NNRTI).INTELE...tment-experiencedadultswhoareexperiencingvirologic...ntiretroviral(ARV)agents.Thetraditionalapprovalisb...andDUET-2.INTELENCEiscurrentlymarketedintheU.S.byT...

Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2 Pharmasset Reports Fiscal Year End 2009 Financial Results 2 Pharmasset Reports Fiscal Year End 2009 Financial Results 3 Pharmasset Reports Fiscal Year End 2009 Financial Results 4 Pharmasset Reports Fiscal Year End 2009 Financial Results 5 Pharmasset Reports Fiscal Year End 2009 Financial Results 6 Pharmasset Reports Fiscal Year End 2009 Financial Results 7 Pharmasset Reports Fiscal Year End 2009 Financial Results 8 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4 Rabies 3A How to Protect Yourself and Your Pets 51990 1 Rabies 3A How to Protect Yourself and Your Pets 51990 2 Sanford Rose Associates Opens Minneapolis Office 13075 1 Sanford Rose Associates Opens Minneapolis Office 13075 2 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 1 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 2 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 3 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 4 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 5 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 6

[0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey [0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)

..., Jan. 7 Hyperion,Therapeutics, Inc., a privately...elopment and commercialization of hepatology and g...underserved patient populations with,unmet medical...been elected,to its Board of Directors and will se...cgi-bin/prnh/20070905/AQW076LOGO ), Mr. Ringo bri...

... AtriCure, Inc.,(Nasdaq: ATRC ), a medical device... products, today announced that results reporting ...oducts, which physicians have adopted to,treat atr...s of Thoracic,Surgery by Dr. James H. Wudel, a pro...braska Heart Hospital, Lincoln, Nebraska., Dr. Wu...

Other Medicine Technology:William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman 2 Positive Results Published Using AtriCure Minimally Invasive Products 2 Positive Results Published Using AtriCure Minimally Invasive Products 3 Positive Results Published Using AtriCure Minimally Invasive Products 4

William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman Positive Results Published Using AtriCure Minimally Invasive Products

ProtecPoint Exit Protection System

... track the movement of controlled substances, crit...ee's "intellishelvess" are designed to perform thi...with no human intervention. Radio frequency identi...rdaSee Intellishelf™ product solutions incorp...

AgileTrac™ Bed and Room Manager

Assetrac Location & Protection System

Medicine Products:

ProtecPoint Exit Protection System VerdaSee Intellishelf™AgileTrac™ Bed and Room Manager Assetrac Location & Protection System

Repligen Elects Earl Henry, M.D. to the Board of...( WALTHAM Mass. Dec. 13 /- Repligen...),Health